Blood pressure level and incidence of myocardial infarction among patients treated for hypertension

American Journal of Public Health

Volumn 89, Issue 9, 1999, Pages 1414-1417

  Kaplan, Robert C ^a   Psaty, Bruce M ^a   Heckbert, Susan R ^a   Smith, Nicholas L ^a   Lemaitre, Rozenn N ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

EID: 0032774595     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.9.1414     Document Type: Article

References (11)

1. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995; 26:60-69.
2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC-VI). Arch Intern Med. 1997;157:2413-2446.
4. Psaty BM, Heckbert SR, Atkins D, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med. 1994;154:1333-1339.
5. Stata Reference Manual: Release 5.0. College Station, Tex: Stata Corp; 1997.
6. Giumetti D, Liu K, Stamler R, Schoenberger JA, Shekelle RB, Stamler J. Need to prevent and control high-normal and high blood pressure, particularly so-called "mild" hypertension: epidemiological and clinical data. Prev Med. 1985; 14:396-412.
7. Du X, Cruickshank K, McNamee R, et al. Casecontrol study of stroke and the quality of hypertension control in north west England. BMJ 1997;314:272-276.
8. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-495.
9. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in men and women. A metaanalysis of individual patient data from randomized, controlled trials. Ann Intern Med. 1997;126:761-767.
10. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
11. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol. 1985;122: 495-506.